A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 194
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : EAN
Long Form : experimental allergic neuritis
No. Year Title Co-occurring Abbreviation
2018 Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis. DAC, GBS
2015 Evidence from Human and Animal Studies: Pathological Roles of CD8(+) T Cells in Autoimmune Peripheral Neuropathies. CIDP, GBS
2010 Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. BNB, BNI
2010 Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis. CFA, MAC
2010 [Dynamic change OX40/OX40L mRNA in experimental allergic neuritis]. OX40, OX40L
2008 Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barre syndrome. CY, GBS, p.i
2007 A role for interferon-beta in Guillain-Barre Syndrome? GBS, IFNbeta, IVIG, TGF-beta1, TNF-alpha
2005 Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barre syndrome and experimental allergic neuritis. GBS, MIF
2005 [Alteration of the auditory function and auditory nerve pathology in Guinea pigs with peripheral nerve demyelination]. ABR, CAP, MBP, NCV
10  2004 Chronic inflammatory demyelinating polyradiculoneuropathy. CIDP
11  2004 Inducible nitric oxide synthase (iNOS) in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. iNOS, NO, PNS
12  2004 [Integrin alpha6 beta4 and experimental allergic neuritis]. ---
13  2003 [Expression and significance of integrin alpha6beta4 in experimental allergic neuritis]. SC
14  2002 Adoptive transfer-experimental allergic neuritis in newborn Lewis rats results in inflammatory infiltrates, mast cell activation, and increased Ia expression with only minor nerve fiber degeneration. PNS
15  2002 Matrix metalloproteinases in neuroinflammation. BBB, CNS, EAE, MMPs, MPs, TIMPs
16  2002 Treatment of rats with experimental allergic neuritis using high dose immunoglobulin. HIG
17  2002 [Cellular aspect of neuroinflammation in Guillain-Barre syndrome: a key to a new therapeutic option?]. GBS
18  2001 Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis. ---
19  2000 Experimental allergic neuritis in the SJL/J mouse: induction of severe and reproducible disease with bovine peripheral nerve myelin and pertussis toxin with or without interleukin-12. BPNM, CFA, mrIL-12, PT
20  2000 Lipid-free versus lipid-bound P2 protein-induced experimental allergic neuritis: clinicopathological, neurophysiological, and immunological study. ---
21  1999 A complementary peptide vaccine that induces T cell anergy and prevents experimental allergic neuritis in Lewis rats. ---
22  1999 Chemokine mRNA expression in the cauda equina of Lewis rats with experimental allergic neuritis. CE, IP, MCP, MIP, p.i, RANTES
23  1999 Chemokines and peripheral nerve demyelination. GBS, MCP-1, MIP, PNS
24  1999 Induction of adhesion molecules on human schwann cells by proinflammatory cytokines, an immunofluorescence study. GBS
25  1999 Schwann cell undergoes apoptosis during experimental allergic neuritis (EAN). p75NTR, PNS
26  1999 The action mechanism of cyclooxygenase-2 inhibitor for treatment of experimental allergic neuritis. COX, LO
27  1999 The expression of CD59 in experimental allergic neuritis. GBS, IFN-gamma, MAC
28  1998 Soluble complement receptor 1 (sCR1) is not as effective as cobra venom factor in the treatment of experimental allergic neuritis. CVF, sCR1, sCR1
29  1998 The effect of cyclooxygenase-2 inhibitor on experimental allergic neuritis. COX
30  1998 The expression of cytokine mRNA in the cauda equina of Lewis rats with experimental allergic neuritis. ---
31  1997 Experimental allergic neuritis: cytolysin mRNA expression is upregulated in lymph node cells during convalescence. BPM, MNC, p.i, PNS
32  1997 Fc portion of intravenous immunoglobulin suppresses the induction of experimental allergic neuritis. IVIG
33  1997 Insights into Campylobacter jejuni-induced Guillain-Barre syndrome from the Lewis rat model of experimental allergic neuritis. GBS
34  1997 The effects of monoamine reuptake inhibiting antidepressants in experimental allergic neuritis. GBS, IFN-gamma, PNS, TNF-beta
35  1996 Dynamics of mRNA expression of interferon-gamma, interleukin 4 and transforming growth factor beta1 in sciatic nerves and lymphoid organs in experimental allergic neuritis. BPM, IFN-gamma, IL-4, p.i, PNS, Th1
36  1996 Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies. ---
37  1996 Oral administration of type I interferon modulates the course of experimental allergic neuritis. IFN
38  1996 Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection. Gc, PIE
39  1996 The antibody repertoire in experimental allergic neuritis: evidence for PMP-22 as a novel neuritogen. AT-EAN, CFA, GBS, MAG, MBP, PNS
40  1996 [Guillain-Barre syndrome and acute disseminated encephalomyelitis (ADEM)]. ADEM, GBS
41  1996 [The role of substance P in the spinal dorsal horn in the pathogenesis of autoimmune diseases]. AA, EAE, SDH, SP
42  1995 Complement depletion affects demyelination and inflammation in experimental allergic neuritis. CVF
43  1995 Intraneural activated T cells cause focal breakdown of the blood-nerve barrier. BNB, HRP, i.n, i.p, Ig, TNF-alpha
44  1995 Low-affinity nerve growth factor receptor expression in sciatic nerve during P2-peptide induced experimental allergic neuritis. NGF
45  1995 Synergy between antibody and P2-reactive T cells in experimental allergic neuritis. i.p
46  1995 The two-color analysis of the T-lymphocyte subsets in experimental allergic neuritis in rats. MHC
47  1994 Axonal Guillain-Barre syndrome. GBS
48  1994 Cellular mRNA expression of interferon-gamma, IL-4 and transforming growth factor-beta (TGF-beta) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis. BPM, IFN-gamma, MNC, TGF-beta
49  1994 Effect of monoamine reuptake inhibiting antidepressants on major histocompatibility complex expression on macrophages in normal rats and rats with experimental allergic neuritis (EAN). ---
50  1994 Effective use of a neurotrophic ACTH4-9 analogue in the treatment of a peripheral demyelinating syndrome (experimental allergic neuritis). An intervention study. GBS
51  1994 Expression of P2 protein by Lewis rat Schwann cells in vitro. PNS
52  1994 Influence of K+ channel openers on interferon-gamma dependent immune response in experimental allergic neuritis (EAN). BPM, IFN-gamma-SC, PHA
53  1994 Lewis rat EAN is suppressed by the 21-aminosteroid tirilazad mesylate (U-74006F). ---
54  1994 Neuritogenic Lewis rat T cells use Tcrb chains that include a new Tcrb-V8 family member. MBP
55  1994 Phosphatidylserine suppresses myelin-induced experimental allergic neuritis (EAN) in Lewis rats. ---
56  1994 Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats. BPM, IFN-gamma, MNC, p.i
57  1994 The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1. BPM, MAG, p.i
58  1994 [Cell therapy and its risks]. EAE
59  1994 [Effects of T4 monomer of Tripterygium wilfordii and artificial musk on experimental allergic neuritis]. ---
60  1993 Adoptive transfer of experimental allergic neuritis in the immune suppressed host. ---
61  1993 Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis. TGF-beta
62  1992 Calcium antagonists suppress experimental allergic neuritis (EAN). ---
63  1992 Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. PNS
64  1992 Effect of stilbene-type anion channel blockers on the immune response during experimental allergic neuritis (EAN). BPM, IFN-gamma, PHA
65  1992 Effects of zimeldine and its metabolites, clomipramine, imipramine and maprotiline in experimental allergic neuritis in Lewis rats. BPM, GBS, IFN-gamma, MNC, PHA
66  1992 Evolution of the cellular response in P2-induced experimental allergic neuritis. ---
67  1992 Immunosuppressive effect of FK506 on experimental allergic neuritis in Lewis rats: change of T cell subsets. ---
68  1992 Influence of gangliosides on experimental allergic neuritis. ---
69  1992 Inhibition of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. BH, CFA, CNS, CREAE, IFA, PNS, SCH
70  1992 Interactions between CD4+ T-cells and rat Schwann cells in vitro. 1. Antigen presentation by Lewis rat Schwann cells to P2-specific CD4+ T-cell lines. MHC, SEM
71  1992 Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein. CMV, EBV, HIV-I, VZV
72  1992 Neuropathological findings in chronic relapsing experimental allergic neuritis induced in the Lewis rat by inoculation with intradural root myelin and treatment with low dose cyclosporin A. CsA
73  1992 Patterns of conduction impairment in experimental allergic neuritis. An electrophysiological and histological study. CMAP
74  1992 Peripheral nervous system (PNS) expression of mRNAs encoding myelin proteins and Fc gamma RIII during experimental allergic neuritis. PNS
75  1992 Peripheral nervous system demyelination from systemic transfer of experimental allergic neuritis serum. 5-HT, CFA, i.p
76  1991 Activated T lymphocyte subsets in experimental allergic neuritis. ---
77  1991 An analysis of mast cell frequency in the rodent nervous system: numbers vary between different strains and can be reconstituted in mast cell-deficient mice. CNS, EAE, PNS
78  1991 Changes of ionic channel distribution in myelinated nerve fibres from rats with experimental allergic neuritis. ---
79  1991 Comparative histology of experimental allergic neuritis induced with minimum length neuritogenic peptides by adoptive transfer with sensitized cells or direct sensitization. BNB
80  1991 Effects of gangliosides on the expression of autoimmune demyelination in the peripheral nervous system. GA, GC
81  1991 Experimental allergic neuritis in the SJL/J mouse: dysfunction of peripheral nerve without clinical signs. PN, PNS
82  1991 Interferon-gamma inhibition suppresses experimental allergic neuritis: modulation of major histocompatibility complex expression of Schwann cells in vitro. DRG, IFN-gamma, LNC, MHC, SCs
83  1991 P2-peptide induced experimental allergic neuritis: a model to study axonal degeneration. ---
84  1991 The refractory phase of experimental allergic encephalomyelitis in the Lewis rat is antigen specific in its induction but not in its effect. EAE, MBP
85  1991 The use of protease inhibitors in experimental allergic neuritis. EACA
86  1991 [Disturbance of immunoregulation in experimental allergic neuritis in rabbits: II. The relationship between the changes in CSF and serum serotonin concentrations and immune responses]. MBP
87  1990 Effect of experimental allergic neuritis serum on normal rat peripheral nerve. ---
88  1990 Gangliosides improve the outcome of experimental allergic neuritis (EAN). CFA, EAE
89  1990 Measurement of atactic and paretic gait in neuropathies of rats based on analysis of walking tracks. ---
90  1990 New minimum length requirement for a T cell epitope for experimental allergic neuritis. ---
91  1990 Oestrogen treatment reduces duration of experimental allergic neuritis in rats and suppresses T cell responses to myelin. ---
92  1990 Plasma serotonergic activation in rats during the course of experimental allergic neuritis. ---
93  1990 Prednisolone therapy of experimental allergic neuritis in Lewis rats does not induce relapsing or chronic disease. ---
94  1990 Proteolysis of peripheral nerve myelin in acute experimental allergic neuritis. ---
95  1990 Spontaneous chemiluminescence activity of peripheral blood cells during experimental allergic neuritis (EAN). CL-A
96  1990 Suppression of actively induced and passively transferred experimental allergic neuritis by cyclosporin A. CyA
97  1990 The effects of prophylactic cyclosporin A on experimental allergic neuritis (EAN) in the Lewis rat. Induction of relapsing EAN using low dose cyclosporin A. CsA
98  1990 [Immunoregulation disturbance in experimental allergic neuritis. The cellular and humoral mediated immunological damage]. MBP
99  1989 A T cell epitope for experimental allergic neuritis is an amphipathic alpha-helical structure. ---
100  1989 Effect of ion channel blockers on immune response and course of experimental allergic neuritis. ---